Repurposing non-pharmacological interventions for Alzheimer's disease through link prediction on biomedical literature

• Published in: Scientific reports 2024-04, Vol.14 (1), p.8693-8693, Article 8693
• Main Authors: Xiao, Yongkang, Hou, Yu, Zhou, Huixue, Diallo, Gayo, Fiszman, Marcelo, Wolfson, Julian, Zhou, Li, Kilicoglu, Halil, Chen, You, Su, Chang, Xu, Hua, Mantyh, William G., Zhang, Rui
• Format: Article
• Language: English
• Subjects: 631/114/2406; 692/699/375/132/1283; 692/700/459/1994; Alzheimer Disease - drug therapy; Alzheimer's disease; Clinical trials; Cognitive ability; Dietary supplements; Embedding; Humanities and Social Sciences; Humans; Information processing; Learning; Life Sciences; multidisciplinary; Neurodegenerative diseases; Photodynamic therapy; Prediction models; Prevention; Psychotherapy; Santé publique et épidémiologie; Science; Science (multidisciplinary)
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-58604-8

Non-pharmaceutical interventions (NPI) have great potential to improve cognitive function but limited investigation to discover NPI repurposing for Alzheimer's Disease (AD). This is the first study to develop an innovative framework to extract and represent NPI information from biomedical literature in a knowledge graph (KG), and train link prediction models to repurpose novel NPIs for AD prevention. We constructed a comprehensive KG, called ADInt, by extracting NPI information from biomedical literature. We used the previously-created SuppKG and NPI lexicon to identify NPI entities. Four KG embedding models (i.e., TransE, RotatE, DistMult and ComplEX) and two novel graph convolutional network models (i.e., R-GCN and CompGCN) were trained and compared to learn the representation of ADInt. Models were evaluated and compared on two test sets (time slice and clinical trial ground truth) and the best performing model was used to predict novel NPIs for AD. Discovery patterns were applied to generate mechanistic pathways for high scoring candidates. The ADInt has 162,212 nodes and 1,017,284 edges. R-GCN performed best in time slice (MR = 5.2054, Hits@10 = 0.8496) and clinical trial ground truth (MR = 3.4996, Hits@10 = 0.9192) test sets. After evaluation by domain experts, 10 novel dietary supplements and 10 complementary and integrative health were proposed from the score table calculated by R-GCN. Among proposed novel NPIs, we found plausible mechanistic pathways for photodynamic therapy and Choerospondias axillaris to prevent AD, and validated psychotherapy and manual therapy techniques using real-world data analysis. The proposed framework shows potential for discovering new NPIs for AD prevention and understanding their mechanistic pathways.